Salud financiera de hoja de balance de BioNeutra Global

Salud financiera controles de criterios 0/6

BioNeutra Global tiene un patrimonio de los accionistas total de CA$-7.5M y una deuda total de CA$7.0M, lo que sitúa su ratio deuda-patrimonio en -93.1%. Sus activos y pasivos totales son CA$15.8M y CA$23.3M respectivamente.

Información clave

-107.6%

Ratio deuda-patrimonio

CA$7.53m

Deuda

Ratio de cobertura de intereses	n/a
Efectivo	CA$470.16k
Patrimonio	-CA$7.00m
Total pasivo	CA$22.65m
Activos totales	CA$15.65m

Actualizaciones recientes sobre salud financiera

Recent updates

Calculating The Fair Value Of BioNeutra Global Corporation (CVE:BGA)

Dec 30

A Look At The Fair Value Of BioNeutra Global Corporation (CVE:BGA)

Aug 24

We Discuss Why BioNeutra Global Corporation's (CVE:BGA) CEO Compensation May Be Closely Reviewed

Sep 15

Is BioNeutra Global (CVE:BGA) Using Too Much Debt?

Jul 12

Is BioNeutra Global (CVE:BGA) Weighed On By Its Debt Load?

Mar 29

Does BioNeutra Global (CVE:BGA) Have A Healthy Balance Sheet?

Dec 14

Análisis de la situación financiera

Pasivos a corto plazo: BGA tiene patrimonio neto negativo. Es una situación más grave que activos a corto plazo que no cubren pasivos a corto plazo.

Pasivo a largo plazo: BGA tiene patrimonio neto negativo. Esta situación es más grave que el hecho de que los activos a corto plazo no cubran los pasivos a largo plazo.

Historial y análisis de deuda-patrimonio

Nivel de deuda: BGA tiene patrimonio negativo, una situación más grave que un alto nivel de endeudamiento.

Reducción de la deuda: BGA tiene patrimonio neto negativo, por lo que no necesitamos comprobar si su deuda se ha reducido con el tiempo.

Hoja de balance

Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: BGA tiene menos de un año de cash runway basado en su flujo de caja libre actual.

Pronóstico de cash runway: BGA tiene menos de un año de cash runway si el flujo de caja libre sigue reduciéndose a tasas históricas de 23% cada año

Salud financiera de hoja de balance de BioNeutra Global

Salud financiera controles de criterios 0/6

Información clave

Actualizaciones recientes sobre salud financiera

Is BioNeutra Global (CVE:BGA) Using Too Much Debt?

Is BioNeutra Global (CVE:BGA) Weighed On By Its Debt Load?

Does BioNeutra Global (CVE:BGA) Have A Healthy Balance Sheet?

Recent updates

First quarter 2024 earnings released: CA$0.02 loss per share (vs CA$0.02 loss in 1Q 2023)

Less than half of directors are independent

Full year 2023 earnings released: CA$0.05 loss per share (vs CA$0.063 loss in FY 2022)

BioNeutra Global Corporation Appoints Stephen Jakeway as Chief Operating Officer

Less than half of directors are independent

Third quarter 2023 earnings released: CA$0.03 loss per share (vs CA$0.027 loss in 3Q 2022)

Less than half of directors are independent

BioNeutra Global Corporation Appoints Mr. Bill Smith to the Board of Directors

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

BioNeutra Global Corporation Announces Executive Changes

Less than half of directors are independent

Full year 2022 earnings released: CA$0.06 loss per share (vs CA$0.061 loss in FY 2021)

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Calculating The Fair Value Of BioNeutra Global Corporation (CVE:BGA)

Less than half of directors are independent

Third quarter 2022 earnings released: CA$0.03 loss per share (vs CA$0.016 loss in 3Q 2021)

Less than half of directors are independent

Now 40% undervalued

A Look At The Fair Value Of BioNeutra Global Corporation (CVE:BGA)

Second quarter 2022 earnings released: CA$0.01 loss per share (vs CA$0.001 loss in 2Q 2021)

Less than half of directors are independent

BioNeutra Global Corporation Appoints Ross Montagano as Chief Operating Officer

Less than half of directors are independent

First quarter 2022 earnings released

BioNeutra Global Corporation, Annual General Meeting, Jul 08, 2022

Full year 2021 earnings released: CA$0.06 loss per share (vs CA$0.08 loss in FY 2020)

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

Less than half of directors are independent

Less than half of directors are independent

We Discuss Why BioNeutra Global Corporation's (CVE:BGA) CEO Compensation May Be Closely Reviewed

Is BioNeutra Global (CVE:BGA) Using Too Much Debt?

First quarter 2021 earnings released: CA$0.03 loss per share (vs CA$0.024 loss in 1Q 2020)

Chairman Peter Watson has left the company

Is BioNeutra Global (CVE:BGA) Weighed On By Its Debt Load?

New 90-day high: CA$0.30

Does BioNeutra Global (CVE:BGA) Have A Healthy Balance Sheet?

Third quarter 2020 earnings released: CA$0.001 loss per share

Bioneutra Global Corporation Announces Executive Appointments

Bioneutra Global Corporation Appoints Bill Smith as Senior Vice President

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Análisis de cash runway

Descubre empresas con salud financiera